Total Payments
$14,438
2024 Payments
$1,150
Companies
55
Transactions
537
Medicare Patients
16,857
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$11,056 (76.6%)
Travel$1,565 (10.8%)
Other$1,050 (7.3%)
Education$766.94 (5.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,056 | 519 | 76.6% |
| Travel and Lodging | $1,565 | 5 | 10.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,050 | 1 | 7.3% |
| Education | $766.94 | 12 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $2,089 | 31 | $0 (2020) |
| Janssen Biotech, Inc. | $1,593 | 98 | $0 (2024) |
| Astellas Pharma US Inc | $1,345 | 53 | $0 (2024) |
| Cook Incorporated | $1,327 | 6 | $0 (2017) |
| Teleflex LLC | $1,193 | 16 | $0 (2024) |
| ABBVIE INC. | $777.40 | 51 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $659.36 | 39 | $0 (2024) |
| Boston Scientific Corporation | $591.98 | 16 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $569.95 | 25 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $544.63 | 30 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,150 | 51 | Sumitomo Pharma America, Inc. ($312.43) |
| 2023 | $1,682 | 75 | Teleflex LLC ($452.75) |
| 2022 | $1,797 | 81 | Teleflex LLC ($398.68) |
| 2021 | $1,570 | 71 | COLOPLAST CORP ($230.71) |
| 2020 | $696.99 | 40 | AbbVie Inc. ($103.88) |
| 2019 | $1,766 | 75 | Boston Scientific Corporation ($453.16) |
| 2018 | $2,574 | 75 | NeoTract Inc. ($1,289) |
| 2017 | $3,201 | 69 | Cook Incorporated ($1,327) |
All Payment Transactions
537 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/10/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: HORMONE THERAPY | ||||||
| 12/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $0.76 | General |
| Category: HORMONE THERAPY | ||||||
| 11/26/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | AKEEGA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: HORMONE THERAPY | ||||||
| 10/29/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $0.66 | General |
| Category: HORMONE THERAPY | ||||||
| 10/28/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: HORMONE THERAPY | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $0.63 | General |
| Category: HORMONE THERAPY | ||||||
| 10/15/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $19.04 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | Edap Technomed Inc | — | Food and Beverage | Cash or cash equivalent | $21.00 | General |
| 09/04/2024 | Edap Technomed Inc | — | Food and Beverage | Cash or cash equivalent | $21.00 | General |
| 09/04/2024 | Edap Technomed Inc | — | Food and Beverage | Cash or cash equivalent | $21.00 | General |
| 08/21/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/20/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $18.16 | General |
| Category: Prostate cancer | ||||||
| 08/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Oncology | ||||||
| 08/08/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Oncology | ||||||
| 07/31/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Oncology | ||||||
| 07/24/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $212.13 | General |
| Category: HORMONE THERAPY | ||||||
| 07/24/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $0.69 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 4,675 | 28,396 | $2.4M | $652,234 |
| 2022 | 46 | 3,839 | 17,281 | $1.7M | $437,240 |
| 2021 | 56 | 4,227 | 22,591 | $1.8M | $500,662 |
| 2020 | 44 | 4,116 | 21,964 | $1.8M | $501,381 |
Total Patients
16,857
Total Services
90,232
Medicare Billing
$2.1M
Procedure Codes
223
All Medicare Procedures & Services
223 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 57 | 9,360 | $424,565 | $174,173 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 414 | 638 | $171,767 | $54,988 | 32.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 46 | 381 | $182,118 | $52,238 | 28.7% |
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 21 | 882 | $105,470 | $52,194 | 49.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 395 | 532 | $96,910 | $31,442 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 245 | 348 | $93,612 | $24,366 | 26.0% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 90 | 92 | $83,536 | $24,272 | 29.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 133 | 491 | $64,812 | $22,231 | 34.3% |
| 53854 | Destruction of prostate tissue using radiofrequency induced heated water vapor | Office | 2023 | 17 | 17 | $68,646 | $20,478 | 29.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 97 | 149 | $54,236 | $18,414 | 34.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 87 | 144 | $52,416 | $14,660 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 235 | 301 | $54,782 | $13,534 | 24.7% |
| J9155 | Injection, degarelix, 1 mg | Office | 2023 | 14 | 4,000 | $36,000 | $13,017 | 36.2% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 69 | 70 | $58,520 | $12,383 | 21.2% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 26 | 30 | $62,220 | $11,819 | 19.0% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 87 | 87 | $49,503 | $11,694 | 23.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 152 | 178 | $98,078 | $9,918 | 10.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $35,190 | $9,645 | 27.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 39 | 47 | $25,897 | $6,851 | 26.5% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 86 | 107 | $26,322 | $5,257 | 20.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 57 | 57 | $23,598 | $5,131 | 21.7% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 202 | 284 | $20,732 | $5,105 | 24.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 69 | $13,869 | $3,930 | 28.3% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 37 | 45 | $22,590 | $3,290 | 14.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 262 | 386 | $4,632 | $3,235 | 69.8% |
About Dr. John Horgan, M.D
Dr. John Horgan, M.D is a Urology healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568465680.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Horgan, M.D has received a total of $14,438 in payments from pharmaceutical and medical device companies, with $1,150 received in 2024. These payments were reported across 537 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($11,056).
As a Medicare-enrolled provider, Horgan has provided services to 16,857 Medicare beneficiaries, totaling 90,232 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 223 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Omaha, NE
- Active Since 05/23/2005
- Last Updated 03/27/2013
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568465680
Products in Payments
- UROLIFT (Device) $1,928
- ORGOVYX (Drug) $818.53
- Erleada (Drug) $789.64
- ERLEADA (Drug) $739.91
- Cook Medical Accessories (Device) $733.99
- XTANDI (Drug) $630.56
- Urolift - UL400 (Device) $580.66
- PROVENGE (Drug) $544.63
- Cook Medical Urology (Device) $543.18
- LUPRON DEPOT (Drug) $467.54
- UroLift (Device) $458.60
- Xofigo (Drug) $400.14
- UroLift System (Device) $314.51
- GENERAL THERAPIES (Device) $281.05
- ZYTIGA (Drug) $251.64
- Endocare Cryocare System (Medical Supply) $233.89
- PROLARIS (Device) $197.24
- REZUM (Device) $172.11
- Nubeqa (Drug) $169.81
- Trelstar (Drug) $159.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Omaha
John Bishay, M.d, M.D
Urology — Payments: $74,636
Urology $74,636
Stefanie Bolte
Urology — Payments: $59,432
Urology $59,432
Dr. Judson Davies, M.d, M.D
Urology — Payments: $22,630
Urology $22,630
Euclid De Souza, M.d, M.D
Urology — Payments: $15,794
Urology $15,794
Dr. Stephen Leslie, M.d, M.D
Urology — Payments: $13,487
Urology $13,487
Dr. Jon Morton, Md, MD
Urology — Payments: $13,396
Urology $13,396